Oriola Oyj (HEL:ORIOLA)

Market Cap	203.18M
Revenue (ttm)	1.81B
Net Income (ttm)	-30.80M
Shares Out	181.41M
EPS (ttm)	-0.17
PE Ratio	n/a
Forward PE	13.33
Dividend	0.07 (6.33%)
Ex-Dividend Date	Apr 3, 2025

Volume	208,354
Average Volume	63,481
Open	1.106
Previous Close	1.106
Day's Range	1.098 - 1.120
52-Week Range	0.873 - 1.156
Beta	0.42
RSI	65.29
Earnings Date	Jul 18, 2025

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1907
• Employees: 934
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: ORIOLA

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.